A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)
10 Downloads (Pure)
Original languageEnglish
JournalPharmacoeconomics (Print)
DOIs
Publication statusPublished - 2015

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this